By Denny Jacob Heron Therapeutics said Friday it appointed Ira Duarte as chief financial officer. The commercial-stage biotechnology company said Duarte most.
SAN DIEGO, June 23, 2023 /PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet.
/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing.